| Project/Area Number |
23890161
|
|---|
| Research Category |
Grant-in-Aid for Research Activity Start-up
|
| Allocation Type | Single-year Grants |
|---|
| Research Field |
Medical pharmacy
|
|---|
| Research Institution | Kumamoto University |
|---|
Principal Investigator |
HIGASHI Taishi 熊本大学, 大学院・生命科学研究部, 助教 (20613409)
|
|---|
| Project Period (FY) |
2011 – 2012
|
| Project Status |
Completed (Fiscal Year 2012)
|
| Budget Amount *help |
¥3,250,000 (Direct Cost: ¥2,500,000、Indirect Cost: ¥750,000)
Fiscal Year 2012: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2011: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
|
|---|
| Keywords | シクロデキストリン / ポリエチレングリコール / タンパク質 / 超分子 / 制御放出 / インスリン / 包接複合体 / ドラッグデリバリー / 血中滞留性 / 光応答性 |
|---|
| Research Abstract |
The purpose of this study is to design the reversible PEGylation of proteins throughthe interaction of cyclodextrin (CyD) and guest-molecule modified polyethylene glycol(PEG). First, we prepared the insulin conjugate with glucuronylglucosyl- -CyD (GUG- -CyD). Thermostability and enzymatic stability of the conjugate were improved compared toinsulin alone. However, the hypoglycemic effect of the insulin was lost by theconjugation with GUG- -CyD.Next, we prepared insulin conjugate with guest-molecule (adamantane), and thisconjugate retained the activity compared to intact insulin. In addition, supramolecularPEGylated insulin, consisting insulin/adamantine conjugate and PEGylated -CyD showedprolonged hypoglycemic effect compared to insulin alone and insulin/adamantineconjugate.The results suggest that supramolecular PEGylation increases circulating half-life ofprotein drugs without loss of the activity.
|
